Replimune Group, Inc. (REPL) intrinsic value & 10-year financials
Replimune Group, Inc. (REPL) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $10.86
- Market cap
- $1.0B
- Revenue (FY2026)
- —
- ROIC (10-yr avg)
- -55.9%
- Free cash flow (FY2026)
- -$284.6M
REPL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2026 | — | -$313.9M | -$3.38 | -$284.6M | — | -144.6% |
| FY2025 | — | -$247.3M | -$3.07 | -$198.9M | — | -69.9% |
| FY2024 | — | -$215.8M | -$3.24 | -$191.1M | — | -56.0% |
| FY2023 | — | -$174.3M | -$2.99 | -$130.3M | — | -44.3% |
| FY2022 | — | -$118.0M | -$2.26 | -$84.5M | — | -34.8% |
| FY2021 | — | -$80.9M | -$1.75 | -$63.8M | — | -31.4% |
| FY2020 | — | -$52.6M | — | -$67.1M | — | -39.9% |
| FY2019 | — | -$30.8M | — | -$28.0M | — | -26.1% |
| FY2018 | — | -$19.7M | — | -$16.1M | — | — |
| FY2017 | — | -$7.7M | — | -$7.3M | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Replimune Group, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Replimune Group, Inc. has historically struggled to out-earn its cost of capital, averaging just -55.9% ROIC.
Replimune Group, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Replimune Group, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.